Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

NCT05609695 ·Status: UNKNOWN

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

NCT06669377 ·Status: RECRUITING

Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

NCT05278195 ·Status: UNKNOWN

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

NCT05535998 ·Status: COMPLETED

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

NCT02873442 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

NCT06530784 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

NCT05025592 ·Status: UNKNOWN

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

NCT04988945 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

NCT05487443 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

NCT05718492 ·Status: RECRUITING ·Phase: NA

A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC

NCT03116984 ·Status: UNKNOWN ·Phase: PHASE3

Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy

NCT03817736 ·Status: COMPLETED ·Phase: PHASE2

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

NCT05717738 ·Status: RECRUITING

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

NCT05332821 ·Status: COMPLETED

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

NCT03782831 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma

NCT06867432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

NCT06408753 ·Status: COMPLETED

Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

NCT06607120 ·Status: RECRUITING

Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC

NCT03243916 ·Status: UNKNOWN ·Phase: NA

Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular Carcinoma

NCT06715072 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

NCT04975932 ·Status: COMPLETED

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

NCT01352728 ·Status: COMPLETED ·Phase: PHASE2

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

NCT05717400 ·Status: TERMINATED ·Phase: PHASE4

TACE-HAIC vs. HAIC for Potentially Resectable HCC

NCT03591705 ·Status: UNKNOWN ·Phase: NA

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

NCT05811481 ·Status: RECRUITING